Atlas Trials

Low-to-intermediate-risk Prostate Carcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Low-to-intermediate-risk Prostate Carcinoma

RecordFirmDate
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L) (NCT06461819)Samsung Medical Center2023-08-11

Track Low-to-intermediate-risk Prostate Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.